This week, five pharmacy ‘middlemen’ head to Capitol Hill’s hot seat. Some of them have an easier defense than others

(By Nicholas Florko for STAT)

WASHINGTON — President Trump has blasted them as “middlemen,” known for their “dishonest double dealing.”¹ Key Democrats decry the industry as a “black box”² under a “veil of secrecy.”³ Pharmaceutical companies, pharmacists and doctors incessantly pummel them, in ads and in testimony, as the key culprits behind the nation’s rising drug prices.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.